ecrin-mdr-crcClinical2016IPD Sharing (as of May 2020): UndecidedMetastatic Colorectal CancerColorectal NeoplasmsMetastatic Colorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2242650Taiwan4GI toxicitySilymarinCPT-11(irinotecan)ECRIN MDRCompletedfalseThe Efficacy of Silymarin as Adjuvant Therapy on Colorectal Cancer Patients Undergoing FOLFIRI TreatmentPrimary objectives: Use both listed and relatively safe drug, Silymarin,s to improve the intestinal side effect of the patients undergoing FOLFIRI chemotherapy.2016-04-152242650NCT03130634